A 45-year-old male with schizophrenia and a history of multiple hospitalizations for medication nonadherence presents for a routine outpatient visit. He was discharged three months ago on olanzapine 20 mg daily after his most recent hospitalization. He reports taking his medication every day and denies any side effects. His presentation appears stable with no overt psychotic symptoms, appropriate affect, and organized thought process. However, his mother, who manages his medications, called the clinic before the visit expressing concern that she has found full pill organizer compartments untouched on multiple occasions over the past month. A urine drug test for prescribed medication monitoring returns negative for olanzapine metabolites. His BMI has decreased from 34.2 at discharge to 31.8 over three months. The PMHNP is evaluating the medication adherence data in the context of the clinical presentation. Which of the following best represents the appropriate evaluation?